Literature DB >> 11673521

Differential developmental regulation and functional effects on pre-TCR surface expression of human pTalpha(a) and pTalpha(b) spliced isoforms.

A R Ramiro1, M N Navarro, A Carreira, Y R Carrasco, V G de Yébenes, G Carrillo, J L San Millán, B Rubin, M L Toribio.   

Abstract

Functional rearrangement at the TCRbeta locus leads to surface expression on developing pre-T cells of a pre-TCR complex composed of the TCRbeta-chain paired with the invariant pre-TCRalpha (pTalpha) chain and associated with CD3 components. Pre-TCR signaling triggers the expansion and further differentiation of pre-T cells into TCRalphabeta mature T cells, a process known as beta selection. Besides the conventional pTalpha transcript (termed pTalpha(a)), a second, alternative spliced, isoform of the pTalpha gene (pTalpha(b)) has been described, whose developmental relevance remains unknown. In this study, phenotypic, biochemical, and functional evidence is provided that only pTalpha(a) is capable of inducing surface expression of a CD3-associated pre-TCR complex, which seems spontaneously recruited into lipid rafts, while pTalpha(b) pairs with and retains TCRbeta intracellularly. In addition, by using real-time quantitative RT-PCR approaches, we show that expression of pTalpha(a) and pTalpha(b) mRNA spliced products is differentially regulated along human intrathymic development, so that pTalpha(b) transcriptional onset is developmentally delayed, but beta selection results in simultaneous shutdown of both isoforms, with a relative increase of pTalpha(b) transcripts in beta-selected vs nonselected pre-T cells in vivo. Relative increase of pTalpha(b) is also shown to occur upon pre-T cell activation in vitro. Taken together, our data illustrate that transcriptional regulation of pTalpha limits developmental expression of human pre-TCR to intrathymic stages surrounding beta selection, and are compatible with a role for pTalpha(b) in forming an intracellular TCRbeta-pTalpha(b) complex that may be responsible for limiting surface expression of a pTalpha(a)-containing pre-TCR and/or may be competent to signal from a subcellular compartment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673521     DOI: 10.4049/jimmunol.167.9.5106

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Identification of the pre-T-cell receptor alpha chain in nonmammalian vertebrates challenges the structure-function of the molecule.

Authors:  Philippe Smelty; Céline Marchal; Romain Renard; Ludivine Sinzelle; Nicolas Pollet; Dominique Dunon; Thierry Jaffredo; Jean-Yves Sire; Julien S Fellah
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

2.  Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.

Authors:  Diana Bellavia; Antonio F Campese; Saula Checquolo; Anna Balestri; Andrea Biondi; Giovanni Cazzaniga; Urban Lendahl; Hans J Fehling; Adrian C Hayday; Luigi Frati; Harald von Boehmer; Alberto Gulino; Isabella Screpanti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  T lymphoid differentiation in human bone marrow.

Authors:  Florian Klein; Niklas Feldhahn; Sanggyu Lee; Hui Wang; Fiammetta Ciuffi; Mirko von Elstermann; María L Toribio; Heinrich Sauer; Maria Wartenberg; Varun Singh Barath; Martin Krönke; Peter Wernet; Janet D Rowley; Markus Müschen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

4.  Synergistic effects of interleukin-7 and pre-T cell receptor signaling in human T cell development.

Authors:  Ekta S Patel; Lung-Ji Chang
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

5.  Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells.

Authors:  Román Galetto; Celine Lebuhotel; Laurent Poirot; Agnès Gouble; Maria L Toribio; Julianne Smith; Andrew Scharenberg
Journal:  Mol Ther Methods Clin Dev       Date:  2014-06-11       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.